Publications by authors named "Benoit Bareau"

Claim this Profile
L
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia.
Véronique Leblond, Jean-Richard Eveillard, Driss Chaoui, Doriane Cavalieri, Caroline Dartigeas, Benoît Bareau

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial.
Salomon Manier, Jérôme Lambert, Cyrille Hulin, Margaret Macro, Kamel Laribi, Benoit Bareau

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY Study.
Titouan Cazaubiel, Olivier Decaux, Bruno Royer, Denis Caillot, Arthur Bobin, Benoit Bareau

Clin Hematol Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with highrisk cytogenetics: the IFM 2014-01 study.
Arthur Bobin, Salomon Manier, Joe De Keizer, Jaydeep K Srimani, Cyrille Hulin, Benoît Bareau

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial.
Xavier Leleu, Cyrille Hulin, Jerome Lambert, Arthur Bobin, Aurore Perrot, Benoit Bareau

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Benoit Bareau

Br J Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Ronan Le Calloch, Benoit Bareau

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.
Brigitte Pegourie, Lionel Karlin, Lotfi Benboubker, Frédérique Orsini-Piocelle, Mourad Tiab, Benoit Bareau

Am J Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switches of tyrosine-kinase inhibitors in chronic phase of chronic myeloid leukemia in real life.
James Norwood, Cédric Pastoret, Odile Luycx, Marie-Françoise Le Coz, Philippe Moreau, Benoit Bareau

Am J Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases.
Alexandra Audemard, Thierry Lamy, Benoît Bareau, Flore Sicre, Felipe Suarez

Semin Arthritis Rheum· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.
Benoît Bareau, Jérôme Rey, Mohamed Hamidou, Jean Donadieu, Jeff Morcet

Haematologica· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inorganic arsenic induces necrosis of human CD34-positive haematopoietic stem cells.
Laurent Vernhet, Claudie Morzadec, Julien van Grevenynghe, Benoît Bareau, Michel Corolleur

Environ Toxicol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin versus liposomal amphotericin B for empirical therapy.
Pierre Tattevin, Benoît Bareau, Christophe Camus

N Engl J Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis